09/30/2026
Exciting news for the future of critical care medicine! 🎉
We're proud that WashU Medicine is one of the clinical sites for this multi-institutional initiative, with our own Dr. Isaiah Turnbull contributing to this groundbreaking work. The project, called ReSCUED, could reduce ICU length of stay by as much as 25% by modeling a patient's unique immune response in real time — a huge step forward for treating conditions like sepsis, severe trauma, and burns.
Congratulations to Dr. An and the entire ReSCUED team at University of Vermont, and to everyone at WashU Medicine involved in this effort. We're excited to be part of it!
What if doctors could test a customized treatment on a virtual version of a critically ill patient before administering it in real life? That’s the promise behind an innovative research project at UVM.
Gary An, M.D., a University of Vermont trauma surgeon and researcher at The Robert Larner, M.D. College of Medicine at The University of Vermont, has received a research and development contract from Advanced Research Projects Agency for Health worth up to $38 million, the largest research award in UVM history, to develop AI-powered “digital twins” to help clinicians personalize treatment for critically ill patients.
By continuously analyzing molecular and clinical data to model a patient’s unique immune response in real time, the technology could help clinicians evaluate potential treatments before administering them, provide more personalized care, and choose the right treatment at the right time.
If successful, researchers believe the technology could reduce ICU stays by at least 25% and lay the foundation for a new approach to personalized medicine.
Learn more about how UVM researchers are pioneering the future of medicine: https://go.uvm.edu/twin